bionomics-rgb-1024px.png
Bionomics Limited Announces Closing of US$5 Million Underwritten Offering of American Depositary Shares in the United States
21 nov. 2022 18h13 HE | Bionomics Ltd
ADELAIDE, Australia, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (“Bionomics” or the “Company”), a clinical-stage biopharmaceutical company developing novel,...
Kymanox Named as Winner of 2022 Triangle Business Journal Fast 50 Award
21 nov. 2022 16h03 HE | Kymanox
Research Triangle Park, North Carolina, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company exclusively serving the Life Science industry, announced...
Kraig Biocraft Laboratories Completes Closeout of $8 Million Financing, Extinguishing All Convertible Debentures with Yorkville Advisors
21 nov. 2022 07h05 HE | Kraig Biocraft Laboratories
ANN ARBOR, Mich., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and...
ibn-iw-globe-2.png
IBN Is an Official Media Sponsor of RHK’s 2022 Disruptive Growth Conference
18 nov. 2022 12h40 HE | InvestorBrandNetwork (IBN)
LOS ANGELES, Nov. 18, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (“InvestorBrandNetwork”), a multifaceted communications organization with 50+ brands such as InvestorWire, is pleased to...
Kane Logo Cropped TransBG.png
Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 – Conference Call to Follow
17 nov. 2022 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
bionomics-rgb-1024px.png
Bionomics Limited Announces Pricing of Underwritten Offering of American Depositary Shares in the United States
16 nov. 2022 18h36 HE | Bionomics Ltd
ADELAIDE, Australia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (“Bionomics” or the “Company”), a clinical-stage biopharmaceutical company developing novel,...
TRESTLE Compliance and qordata Announce Consulting/Technology Partnership
16 nov. 2022 08h45 HE | TRESTLE Compliance
BOSTON, Nov. 16, 2022 (GLOBE NEWSWIRE) -- TRESTLE Compliance, an industry leader providing smart compliance solutions, risk assessments and complete regulatory, legal and investor support for...
Virogin Biotech Announces Dosing the First US Patient in a Phase 1 Study of VG201 for Patients With Advanced Solid Tumors
15 nov. 2022 16h00 HE | Virogin Biotech
VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Virogin Biotech, a clinical-stage biotech company, today announced that the first patient has been dosed in its Phase 1 clinical study...
BriaCell CEO Discusses Positive Clinical Results of its Breast Cancer Immunotherapy Treatment in an Audio Interview with SmallCapVoice.com
15 nov. 2022 08h00 HE | Briacell Therapeutics Corp.
AUSTIN, Texas, Nov. 15, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new audio interview with Dr. Bill Williams, CEO of BriaCell Therapeutics Corp....
Kraig Biocraft Laboratories poised to Close Out Yorkville Convertible Debenture with Strongest Financial Position in Corporate History
15 nov. 2022 07h05 HE | Kraig Biocraft Laboratories
ANN ARBOR, Mich., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), the biotechnology company focused on the development and...